Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 292 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| IL17RC | ENSG00000163702 | 0.00 | 0.00 | 0 | 0 |
| TDRD7 | ENSG00000196116 | 0.00 | 0.00 | 0 | 0 |
| SLC35A5 | ENSG00000138459 | 0.00 | 0.00 | 0 | 0 |
| CDK17 | ENSG00000059758 | 0.00 | 0.00 | 0 | 0 |
| CACNG3 | ENSG00000006116 | 0.00 | 0.00 | 0 | 0 |
| VRK3 | ENSG00000105053 | 0.00 | 0.47 | 0 | 2 |
| ATP2C1 | ENSG00000017260 | 0.00 | 0.00 | 0 | 0 |
| SLC25A1 | ENSG00000100075 | 0.17 | 0.00 | 1 | 0 |
| CASP7 | ENSG00000165806 | 0.00 | 0.17 | 0 | 1 |
| ICK | ENSG00000112144 | 0.00 | 0.00 | 0 | 0 |
| PARL | ENSG00000175193 | 0.39 | 0.00 | 2 | 0 |
| PIK3R2 | ENSG00000105647 | 0.00 | 0.00 | 0 | 0 |
| LYG2 | ENSG00000185674 | 0.00 | 0.00 | 0 | 0 |
| ADCK4 | ENSG00000123815 | 0.00 | 0.11 | 0 | 1 |
| NPFFR1 | ENSG00000148734 | 0.00 | 0.00 | 0 | 0 |
| HTT | ENSG00000197386 | 0.00 | 0.00 | 0 | 0 |
| PRDM4 | ENSG00000110851 | 0.00 | 0.00 | 0 | 0 |
| CYP20A1 | ENSG00000119004 | 0.00 | 0.00 | 0 | 0 |
| STK38 | ENSG00000112079 | 0.00 | 0.00 | 0 | 0 |
| STK40 | ENSG00000196182 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 292 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.